Cataract Surgery
Customize your policy alerts
Sign up for Aetna Policy 0508 alerts
Get alerted when Policy 0508 changes without checking for updates manually.
Monitor payer policy activity
Clinical policy governing medical necessity, coverage, and coding for cataract surgery, pre-operative testing, intraocular lenses, and related procedures for Aetna members.
No material clinical or coverage changes in this revision.
Coverage Criteria
Initial cataract surgery medical necessity
Covered when ALL of the following are met for members with visual disability:
Standard 20/50 criteria
- Subjective: Member perceives impaired ability to carry out needed or desired activities (e.g., driving, reading, occupational tasks); decision based on personal assessment of visual disability and lifestyle impact
Includes near vision concerns and impact on driving/work
- Objective: Best correctable Snellen visual acuity in the affected eye is 20/50 or worse; eye exam confirms cataract is the limiting factor and other factors do not preclude improvement; member medically/mentally fit for surgery20/50
- Educational: Member has been educated about risks, benefits, alternatives and determines expected benefit outweighs risks, cost and inconvenience
20/40 (better) with additional criteria
- Subjective: Member perceives impairment; includes complaints of disabling glare in bright ambient light inconsistent with dark-room acuity
Requires documentation of loss of vision in bright light
- Objective: Either significant loss of visual acuity in bright ambient light confirmed by glare testing/BAT/contrast sensitivity OR monocular diplopia/polyopia OR inter-eye visual disparity (anisometropia)
Eye exam must confirm cataract is limiting factor and surgery is safe
- Educational/Health: Member educated about risks/benefits and medically/mentally fit for surgery
Includes cases of zonulysis, pseudo-exfoliation, ectopia lentis and indication for capsular tension ring when integral to surgery (CTR not separately reimbursed)
Nd:YAG capsulotomy
Covered when ALL of the following are met:
Requests within 6 months should be forwarded for medical review; prophylactic or concurrent Nd:YAG at time of cataract surgery is considered investigational
Experimental and Investigational
Considered experimental/investigational (not covered) due to insufficient evidence:
Specified specialized pre-operative tests (corneal pachymetry, corneal topography, electrophysiologic tests including ERG, external ocular photography, fluorescein angiography, formal visual fields, specialized color vision tests, specular microscopy, contact/immersion B-scan, visual evoked potentials) are considered experimental/investigational for routine pre-operative evaluation when cataract is the sole indication
Standard cataract surgery and standard IOLs
Covered when meeting standard surgical and clinical indications for cataract removal and IOL implantation:
Standard monofocal IOLs are considered standard; supported by Panel and AAO guidance
Premium and refractive IOLs
Coverage and medical necessity determinations for non-standard IOLs:
Refractive IOLs or IOLs implanted solely for refractive purposes are excluded if refractive surgery is excluded by contract; CMS ruling treats presbyopia‑correcting function as non-covered benefit
Adjunctive devices (CTR) and YAG capsulotomy
Adjuncts and post-operative procedures:
CTR is integral to the surgical procedure and not separately reimbursed; evidence shows low implantation rates (about 0.75–0.97%) and RCT data support improved toric IOL rotational stability when CTR is co‑implanted
Panel found PCO is uncommon within first 6 months and advised against routine or prophylactic capsulotomy
Evidence summaries relevant to coverage decisions
Key evidence summaries and comparative outcomes
See randomized trials and meta-analyses (e.g., Takakura et al, Cochrane evidence)
Prospective randomized trials report increased dysphotopsia and variable contrast sensitivity
Some trials in uveitic eyes show similar visual improvement across materials but mixed complication profiles
Selective use of B‑scan ultrasound is medically necessary when posterior segment cannot be visualized
Cataract removal is considered not medically necessary when the member achieves satisfactory functional vision with glasses or other visual aids, when the member’s lifestyle is not compromised by the cataract, or when the member is medically unfit and surgery will not improve independence (for example, comatose patients, end-stage dementia, or no light perception). Providers should document that conservative measures were tried or remain satisfactory before electing surgery.
Intraocular lens (IOL) implants performed solely for refractive purposes, or implanted in conjunction with refractive procedures (e.g., LASIK), are excluded when those refractive procedures are not covered by the member’s contract. Multifocal, accommodating, and other refractive IOLs whose intent is to obviate the need for glasses are treated as non-covered new-technology items even though the cataract surgery itself may be medically necessary if standard criteria are met.
The policy explicitly lists certain HCPCS codes as not covered for the indications in this bulletin: Q1004, Q1005, V2702, V2755, V2787, V2788. Use of these codes for the non-covered functions described in this CPB may be denied.
A 2005 CMS determination concluded that the presbyopia-correcting function of an IOL is equivalent to providing refractive correction (similar to eyeglasses) and is not a covered benefit. Consequently, additional provider services or charges associated specifically with inserting or monitoring a presbyopia-correcting IOL (for example, postoperative refractive exams tied solely to the presbyopia-correcting function) are not a covered benefit and should not be submitted for coverage as a distinct reimbursable service.
A Cochrane review found no randomized or quasi-randomized trials comparing cataract removal versus no surgery for cataracts that developed after vitrectomy. This represents an evidence gap rather than a prescriptive exclusion; clinical decisions for post‑vitrectomy cataract should be individualized and documented due to the lack of RCT evidence.
Clinical Policy Bulletins are developed to assist in administering plan benefits and provide a partial, general description of those benefits. They do not constitute a contract or guarantee of coverage or outcomes. Treating providers remain responsible for medical advice and treatment; the bulletin may be updated and coverage determinations are subject to change.
Aetna considers the following new-technology IOL types as non-covered deluxe or not medically necessary when intended to reduce dependence on glasses: multifocal, accommodating, toric, extended depth-of-focus (EDOF), trifocal, and light-adjustable IOLs. When these lenses are elected by the member, the cataract removal may be covered if standard criteria are met but the premium/new-technology lens itself is non-covered.
Multifocal and accommodating IOLs are considered not medically necessary when the primary intent is to eliminate the need for reading glasses or contact lenses after surgery. If a member elects these lenses, the device is treated as a non-covered item and should be billed accordingly; the underlying cataract surgery remains subject to standard medical necessity criteria.
The policy reiterates the CMS determination that the presbyopia-correcting function of certain IOLs is not a covered benefit. Providers should therefore recognize that services and supplies billed specifically for the presbyopia-correcting aspect of an IOL (and related postoperative services provided solely for that purpose) are not eligible for coverage under this policy.
Femtosecond laser-assisted cataract surgery (FLACS) has not been demonstrated to be cost-effective versus conventional phacoemulsification at current additional costs in published cost-effectiveness analyses. Routine use of FLACS for all patients is not supported on a cost-effectiveness basis; if FLACS or other premium services are offered, additional patient charges are permissible only after prior discussion and documented informed consent.
Coding
| 66820 | Discission of secondary membranous cataract (opacified posterior lens capsule and/or anterior hyaloid); stab incision technique |
| 66821 | Laser surgery (e.g., YAG laser) (one or more stages) |
| 66830-66986 | Removal of cataract |
| 76511 | Ophthalmic ultrasound, diagnostic; quantitative A-scan only |
| 76516 | Ophthalmic biometry by ultrasound echography, A-scan |
| 76519 | With intraocular lens power calculation |
| 92136 | Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation |
| 92002-92004 | Ophthalmologic services: new patient |
| 92012-92014 | Ophthalmologic services: established patient |
| Q1004 | New technology intraocular lens category 4 as defined in Federal Register notice |
| Q1005 | New technology intraocular lens category 5 as defined in Federal Register notice |
| V2702 | Deluxe lens feature |
| V2755 | U-V lens, per lens |
| V2787 | Astigmatism correcting function of intraocular lens |
| V2788 | Presbyopia correcting function of intraocular lens |
| E08.36,E09.36,E10.36,E11.36,E13.36 | Diabetes mellitus with diabetic cataract |
| H25.011-H26.9 | Cataract |
| H27.00-H27.03 | Aphakia |
| H52.31-H52.32 | Anisometropia and aniseikonia |
| 76512 | B-scan (with or without superimposed non-quantitative A-scan) |
| Q1004 | New technology intraocular lens category 4 as defined in Federal Register notice |
| Q1005 | New technology intraocular lens category 5 as defined in Federal Register notice |
| V2702 | Deluxe lens feature |
| V2755 | U-V lens, per lens |
| V2787 | Astigmatism correcting function of intraocular lens |
| V2788 | Presbyopia correcting function of intraocular lens |
| V2797 | Vision supply, accessory, and/or service component of another HCPCS vision code |
| 76512 | B-scan (with or without superimposed non-quantitative A-scan) |
| E08.36 | Diabetes mellitus with diabetic cataract |
| E09.36 | Diabetes mellitus with diabetic cataract |
| E10.36 | Diabetes mellitus with diabetic cataract |
| E11.36 | Diabetes mellitus with diabetic cataract |
| E13.36 | Diabetes mellitus with diabetic cataract |
| H25.011 | Cataract |
| H26.9 | Cataract |
| H27.00 | Aphakia |
| H27.03 | Aphakia |
| H25.011 | Age-related cataract (listed among ICD-10 not covered for indications in CPB section) |
Provider Actions and Billing Guidance
Prior Authorization and Code-Based Selection
Prior authorization may be required for certain cataract-related procedures and services. Verify payer-specific prior authorization rules for cataract surgery, femtosecond laser-assisted procedures, new-technology IOLs, or adjunctive services before scheduling to avoid claim denials.
- Check payer prior authorization policies for listed CPT/HCPCS codes and for premium IOLs or FLACS-related ancillary services.
Code-Based Coverage Requires Selection Criteria
Coverage of specific CPT/HCPCS codes is conditional on meeting the policy's clinical selection criteria. Codes listed as “covered if selection criteria are met” require documentation demonstrating that medical necessity criteria are fulfilled.
Non-Coverage of Presbyopia-Correcting / Premium IOL Functionality
Presbyopia-correcting, multifocal, accommodating, and other “premium” IOLs are considered not medically necessary when the intent is to reduce dependence on glasses; the lens implant itself is non-covered even if cataract surgery meets medical necessity. Any physician or device services solely attributable to the presbyopia-correcting function are also non-covered.
Patient Consent and Billing for Additional Services
If a patient will be charged extra for premium services (e.g., premium IOLs, FLACS incremental services), the provider must discuss additional out-of-pocket costs in advance and obtain documented informed consent. Extra charges may be billed to the patient only for services that are truly additional to the covered procedure.
- Document prior discussion and signed informed consent for any extra charges.
- Ensure the billed incremental service is distinct from the covered surgery (per ASCRS/ASOA guidance).
Documentation Availability and Risk
Maintain documentation supporting medical necessity and coding decisions; these records must be available upon request. Failure to provide required documentation may lead to claim denial or retrospective payment recovery.
- Required documentation includes: best-corrected Snellen acuity, glare/contrast testing results when applicable, symptom narrative, slit-lamp exam findings, and rationale that cataract is the limiting factor.
- Retain operative notes, pre-operative assessments, and informed-consent forms for audit.
Experimental / Investigational Procedures — Denial Risk
Certain procedures and technologies are considered experimental/investigational and may be denied as not covered. Providers should not expect payment for procedures designated as experimental unless explicit coverage criteria are present.
- Examples listed as experimental/investigational: piggyback posterior chamber IOLs; Nd:YAG capsulotomy when performed concurrently, prophylactically, or routinely without clinically significant posterior capsule opacification.
- Specialized pre-operative services without separate indication (e.g., routine electrophysiologic tests, corneal pachymetry, external photography) are considered of no proven routine value and may be non-covered when used solely for cataract work-up.
Not-Covered HCPCS / CPT Features
Specific HCPCS/CPT codes are identified as not covered for indications in this Clinical Policy Bulletin. Confirm that any HCPCS or CPT code billed is allowable under the member’s benefits and the CPB definitions before submission.
Pre-Operative Testing and B-Scan Considerations
Pre-operative evaluation should include a comprehensive ophthalmologic exam and, when indicated, diagnostic biometry (A-scan or optical coherence biometry). B-scan ultrasonography is appropriate when dense cataract or other factors prevent posterior segment visualization.
- A-scan (76511/76516 with/without IOL power calculation) is used for IOL power determination and billed separately when performed.
- B-scan is indicated for dense/mature cataracts or when the posterior segment cannot be visualized (e.g., Morgagnian cataract) to rule out retinal detachment or vitreous hemorrhage.
Consent, Clinical Rationale, and Inpatient Justification
Document the clinical rationale and informed consent when performing additional or non-routine pre-operative tests, when inpatient cataract surgery is performed, or when charging for premium services. Inpatient cataract surgery requires documentation justifying why outpatient care is not appropriate.
- Inpatient setting may be medically necessary only with documented reasons such as need for prolonged skilled nursing care, multiple complex ocular procedures, severe comorbidities, or functional/incapacitating mental/physical disability.
- Record the clinical indications that make inpatient care or additional testing necessary and include in the medical record.
Provider Responsibility and Policy Disclaimer
Providers are responsible for medical advice and for maintaining current knowledge of policy updates. Clinical Policy Bulletins are tools to assist benefit administration but do not constitute offers of coverage or replace the treating provider’s clinical judgment.
- Treating providers remain responsible for patient care decisions.
- CPBs are subject to change; verify current policy language and member benefit terms when making coverage determinations.
Consideration of FLACS vs Conventional Phaco
When choosing surgical technique, consider that femtosecond laser-assisted cataract surgery (FLACS) has not consistently demonstrated cost-effectiveness or superior overall risk profile compared with conventional phacoemulsification for routine cases. Use conventional phacoemulsification for routine cataract cases unless specific clinical circumstances justify FLACS and the patient has provided informed financial consent for any additional services.
- Document the clinical justification for FLACS and evidence of prior discussion of extra patient costs if any incremental services are billed.
- FLACS may be permissible when used with premium IOLs only after appropriate consent and when charges are for distinct additional services.
Background
Cataract removal with implantation of an intraocular lens is guided by the member’s functional impairment and by objective measures of vision. Standard coverage is generally based on best-corrected Snellen visual acuity thresholds (for example, 20/50 or worse, or 20/40 with documented functional impairment or glare testing). Pre-operative biometry (A‑scan or optical coherence interferometry) is used to calculate IOL power, and diagnostic B‑scan ultrasound is appropriate when dense media prevent posterior-segment visualization (for example, Morgagnian or total cataract). Providers should document subjective impairment, exam findings that cataract is the limiting factor, and that the member was informed of risks, benefits, and alternatives.
Definitions
Revision History
Policy became effective.
Policy underwent routine review (last review date recorded).
Next scheduled policy review date.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.